Skip to main content
Erschienen in: Inflammation Research 6/2014

01.06.2014 | Original Research Paper

Differential effects of low and high doses of lipoteichoic acid on lipopolysaccharide-induced interleukin-6 production

verfasst von: Hangeun Kim, Bong Jun Jung, Joo Yun Kim, Dae Kyun Chung

Erschienen in: Inflammation Research | Ausgabe 6/2014

Einloggen, um Zugang zu erhalten

Abstract

Objective

Interleukin-6 (IL-6), which is increased in patients who are suffering from septic shock, is an important mediator of the inflammatory response. Here, we examined the priming effect of lipoteichoic acid (LTA) and lipopolysaccharide (LPS) on IL-6 production in a monocyte-like cell line.

Methods

THP-1 cells were primed by treatingwith a low or high dose of LTA isolated from Staphylococcus aureus (aLTA) and then re-treated with LPS. IL-6 production, receptor expression, and the variation of signaling molecules were examined by ELISA, reverse transcriptase polymerase chain reaction, and western blotting, respectively.

Results

LPS-mediated IL-6 production was dramatically increased in THP-1 cells pretreated with a low dose aLTA, while it was significantly decreased when a high dose of aLTA was given along with LPS. LPS-induced IL-6 production in low dose aLTA priming cells mediated by NF-κB and MAPKs pathways, and Akt functioned as a negative regulator of IL-6 production. Together, the results of this study suggest that different doses of bacterial cell surface components can mediate a diverse range of responses with respect to inflammatory cytokine production.
Literatur
1.
Zurück zum Zitat Takala A, Nupponen I, Kylänpää-Bäck ML, Repo H. Markers of inflammation in sepsis. Ann Med. 2002;34:614–23.PubMedCrossRef Takala A, Nupponen I, Kylänpää-Bäck ML, Repo H. Markers of inflammation in sepsis. Ann Med. 2002;34:614–23.PubMedCrossRef
2.
Zurück zum Zitat Takala A, Jousela I, Jansson SE, Olkkola KT, Takkunen O, Orpana A, Karonen SL, Repo H. Markers of systemic inflammation predicting organ failure in community-acquired septic shock. Clin Sci. 1999;97:529–38.PubMedCrossRef Takala A, Jousela I, Jansson SE, Olkkola KT, Takkunen O, Orpana A, Karonen SL, Repo H. Markers of systemic inflammation predicting organ failure in community-acquired septic shock. Clin Sci. 1999;97:529–38.PubMedCrossRef
3.
Zurück zum Zitat Hack CE, De Groot ER, Felt-Bersma RJ, Nuijens JH, Strack Van Schijndel RJ, Eerenberg-Belmer AJ, Thijs LG, Aarden LA. Increased plasma levels of interleukin-6 in sepsis. Blood. 1989;74:1704–10.PubMed Hack CE, De Groot ER, Felt-Bersma RJ, Nuijens JH, Strack Van Schijndel RJ, Eerenberg-Belmer AJ, Thijs LG, Aarden LA. Increased plasma levels of interleukin-6 in sepsis. Blood. 1989;74:1704–10.PubMed
4.
Zurück zum Zitat Damas P, Ledoux D, Nys M, Vrindts Y, De Groote D, Franchimont P, Lamy M. Cytokine serum level during severe sepsis in human IL-6 as a marker of severity. Ann Surg. 1992;215:356–62.PubMedCentralPubMedCrossRef Damas P, Ledoux D, Nys M, Vrindts Y, De Groote D, Franchimont P, Lamy M. Cytokine serum level during severe sepsis in human IL-6 as a marker of severity. Ann Surg. 1992;215:356–62.PubMedCentralPubMedCrossRef
5.
Zurück zum Zitat Seo HS, Michalek SM, Nahm MH. Lipoteichoic acid is important in innate immune responses to Gram-positive bacteria. Infect Immunol. 2008;76:206–13.CrossRef Seo HS, Michalek SM, Nahm MH. Lipoteichoic acid is important in innate immune responses to Gram-positive bacteria. Infect Immunol. 2008;76:206–13.CrossRef
6.
Zurück zum Zitat Ginsburg I. Role of lipoteichoic acid in infection and inflammation. Lancet Infect. 2002;2:171–9.CrossRef Ginsburg I. Role of lipoteichoic acid in infection and inflammation. Lancet Infect. 2002;2:171–9.CrossRef
7.
Zurück zum Zitat Fischer W. Physiology of lipoteichoic acids in bacteria. Adv Microb Physiol. 1998;29:233–302.CrossRef Fischer W. Physiology of lipoteichoic acids in bacteria. Adv Microb Physiol. 1998;29:233–302.CrossRef
8.
Zurück zum Zitat Takeuchi O, Hoshino K, Akira S. Cutting edge: TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection. J Immunol. 2000;165:5392–6.PubMedCrossRef Takeuchi O, Hoshino K, Akira S. Cutting edge: TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection. J Immunol. 2000;165:5392–6.PubMedCrossRef
9.
Zurück zum Zitat Schroder NWJ, Morath S, Alexander C, Hamann L, Hartung T, Zahringer U, Gobel UB, Weber JR, Schumann RR. Lipoteichoic acid (LTA) of Streptococcus pneumoniae and Staphylococcus aureus activates immune cells via Toll-like receptor (TLR)-2, lipopolysaccharide-binding protein (LBP), and CD14, whereas TLR-4 and MD-2 are not involved. J Biol Chem. 2003;278:15587–94.PubMedCrossRef Schroder NWJ, Morath S, Alexander C, Hamann L, Hartung T, Zahringer U, Gobel UB, Weber JR, Schumann RR. Lipoteichoic acid (LTA) of Streptococcus pneumoniae and Staphylococcus aureus activates immune cells via Toll-like receptor (TLR)-2, lipopolysaccharide-binding protein (LBP), and CD14, whereas TLR-4 and MD-2 are not involved. J Biol Chem. 2003;278:15587–94.PubMedCrossRef
10.
Zurück zum Zitat Mattsson E, Verhage L, Rollof J, Fleer A, Verhoef J, van Dijk H. Peptidoglycan and teichoic acid from Staphylococcus epidermidis stimulate human monocytes to release tumour necrosis factor-alpha, interleukin-1β and interleukin-6. FEMS Immunol Med Microbiol. 1993;7:281–7.PubMed Mattsson E, Verhage L, Rollof J, Fleer A, Verhoef J, van Dijk H. Peptidoglycan and teichoic acid from Staphylococcus epidermidis stimulate human monocytes to release tumour necrosis factor-alpha, interleukin-1β and interleukin-6. FEMS Immunol Med Microbiol. 1993;7:281–7.PubMed
11.
Zurück zum Zitat Standiford TJ, Arenberg DA, Danforth JM, Kunkel SL, van Otteren GM, Strieter RM. Lipoteichoic acid induces secretion of interleukin-8 from human blood monocytes: a cellular and molecular analysis. Infect Immunol. 1994;62:119–25. Standiford TJ, Arenberg DA, Danforth JM, Kunkel SL, van Otteren GM, Strieter RM. Lipoteichoic acid induces secretion of interleukin-8 from human blood monocytes: a cellular and molecular analysis. Infect Immunol. 1994;62:119–25.
12.
Zurück zum Zitat Ellingsen E, Morath S, Flo T, Schromm A, Hartung T, Thiemermann C, Espevik T, Golenbock D, Foster D, Solberg R, Aasen A, Wang J. Induction of cytokine production in human T cells and monocytes by highly purified lipoteichoic acid: involvement of Toll-like receptors and CD14. Med Sci Monit. 2002;8:149–56. Ellingsen E, Morath S, Flo T, Schromm A, Hartung T, Thiemermann C, Espevik T, Golenbock D, Foster D, Solberg R, Aasen A, Wang J. Induction of cytokine production in human T cells and monocytes by highly purified lipoteichoic acid: involvement of Toll-like receptors and CD14. Med Sci Monit. 2002;8:149–56.
13.
Zurück zum Zitat Kim HG, Kim NR, Gim MG, Lee JM, Lee SY, Ko MY, Kim JY, Han SH, Chung DK. Lipoteichoic acid isolated from Lactobacillus plantarum inhibits lipopolysaccharide-induced TNF-α production in THP-1 cells and endotoxin shock in mice. J Immunol. 2008;180:2553–61.PubMedCrossRef Kim HG, Kim NR, Gim MG, Lee JM, Lee SY, Ko MY, Kim JY, Han SH, Chung DK. Lipoteichoic acid isolated from Lactobacillus plantarum inhibits lipopolysaccharide-induced TNF-α production in THP-1 cells and endotoxin shock in mice. J Immunol. 2008;180:2553–61.PubMedCrossRef
14.
Zurück zum Zitat Kim HG, Lee SY, Kim NR, Ko MY, Lee JM, Yi TH, Chung SK, Chung DK. Inhibitory effects of Lactobacillus plantarum lipoteichoic acid (LTA) on Staphylococcus aureus LTA-induced tumor necrosis factor-alpha production. J Microbiol Biotechnol. 2008;18:1191–6.PubMed Kim HG, Lee SY, Kim NR, Ko MY, Lee JM, Yi TH, Chung SK, Chung DK. Inhibitory effects of Lactobacillus plantarum lipoteichoic acid (LTA) on Staphylococcus aureus LTA-induced tumor necrosis factor-alpha production. J Microbiol Biotechnol. 2008;18:1191–6.PubMed
15.
Zurück zum Zitat Han SH, Kim JK, Martin M, Michalek SM, Nahm MH. Pneumococcal lipoteichoic acid (LTA) is not as potent as Staphylococcal LTA in stimulating Toll-like receptor 2. Infect Immunol. 2003;71:5541–8.CrossRef Han SH, Kim JK, Martin M, Michalek SM, Nahm MH. Pneumococcal lipoteichoic acid (LTA) is not as potent as Staphylococcal LTA in stimulating Toll-like receptor 2. Infect Immunol. 2003;71:5541–8.CrossRef
16.
Zurück zum Zitat Kim HG, Gim MG, Kim JY, Hwang HJ, Ham MS, Lee JM, Hartung T, Park JW, Han SH, Chung DK. Lipoteichoic acid from Lactobacillus plantarum elicits both the production of Interleukin-23p19 and suppression of pathogen-mediated Interleukin-10 in THP-1 cells. FEMS Immunol Med Microbiol. 2007;49:205–14.PubMedCrossRef Kim HG, Gim MG, Kim JY, Hwang HJ, Ham MS, Lee JM, Hartung T, Park JW, Han SH, Chung DK. Lipoteichoic acid from Lactobacillus plantarum elicits both the production of Interleukin-23p19 and suppression of pathogen-mediated Interleukin-10 in THP-1 cells. FEMS Immunol Med Microbiol. 2007;49:205–14.PubMedCrossRef
18.
Zurück zum Zitat van der Poll T, Keogh CV, Guirao X, Buurman WA, Kopf M, Lowry SF. Interleukin-6 gene-deficient mice show impaired defense against pneumococcal pneumonia. J Infect Dis. 1997;176:439–44.PubMedCrossRef van der Poll T, Keogh CV, Guirao X, Buurman WA, Kopf M, Lowry SF. Interleukin-6 gene-deficient mice show impaired defense against pneumococcal pneumonia. J Infect Dis. 1997;176:439–44.PubMedCrossRef
19.
Zurück zum Zitat Olsnes C, Olofsson J, Aarstad HJ. MAPKs ERK and p38, but not JNK phosphorylation, modulate IL-6 and TNF-α secretion following OK-432 in vitro stimulation of purified human monocytes. Scand J Immunol. 2011;74:114–25.PubMedCrossRef Olsnes C, Olofsson J, Aarstad HJ. MAPKs ERK and p38, but not JNK phosphorylation, modulate IL-6 and TNF-α secretion following OK-432 in vitro stimulation of purified human monocytes. Scand J Immunol. 2011;74:114–25.PubMedCrossRef
20.
Zurück zum Zitat Dahle MK, Øverland G, Myhre AE, Stuestøl JF, Hartung T, Krohn CD, Mathiesen Ø, Wang JE, Aasen AO. The phosphatidylinositol 3-kinase/protein kinase B signaling pathway is activated by lipoteichoic acid and plays a role in Kupffer cell production of interleukin-6 (IL-6) and IL-10. Infect Immun. 2004;72:5704–11.PubMedCentralPubMedCrossRef Dahle MK, Øverland G, Myhre AE, Stuestøl JF, Hartung T, Krohn CD, Mathiesen Ø, Wang JE, Aasen AO. The phosphatidylinositol 3-kinase/protein kinase B signaling pathway is activated by lipoteichoic acid and plays a role in Kupffer cell production of interleukin-6 (IL-6) and IL-10. Infect Immun. 2004;72:5704–11.PubMedCentralPubMedCrossRef
21.
Zurück zum Zitat Grangette C, Nutten S, Palumbo E, Morath S, Hermann C, Dewulf J, Pot B, Hartung T, Hols P, Mercenier A. Enhanced antiinflammatory capacity of Lactobacillus plantarum mutant synthesizing modified teichoic acids. Proc Natl Acad Sci USA. 2005;102:10321–6.PubMedCentralPubMedCrossRef Grangette C, Nutten S, Palumbo E, Morath S, Hermann C, Dewulf J, Pot B, Hartung T, Hols P, Mercenier A. Enhanced antiinflammatory capacity of Lactobacillus plantarum mutant synthesizing modified teichoic acids. Proc Natl Acad Sci USA. 2005;102:10321–6.PubMedCentralPubMedCrossRef
22.
Zurück zum Zitat Mohamadzadeh M, Olson S, Kalina WV, Ruthel G, Demmin GL, Warfield KL, Bavari S, Klaenhammer TR. Lactobacilli activate human dendritic cells that skew T cells toward T helper 1 polarization. Proc Natl Acad Sci USA. 2005;102:2880–5.PubMedCentralPubMedCrossRef Mohamadzadeh M, Olson S, Kalina WV, Ruthel G, Demmin GL, Warfield KL, Bavari S, Klaenhammer TR. Lactobacilli activate human dendritic cells that skew T cells toward T helper 1 polarization. Proc Natl Acad Sci USA. 2005;102:2880–5.PubMedCentralPubMedCrossRef
23.
Zurück zum Zitat Bloksma N, de Heer E, van Dijk H, Willers JM. Adjuvanticity of lactobacilli I. Differential effects of viable and killed bacteria. Clin Exp Immunol. 1979;37:367–75.PubMedCentralPubMed Bloksma N, de Heer E, van Dijk H, Willers JM. Adjuvanticity of lactobacilli I. Differential effects of viable and killed bacteria. Clin Exp Immunol. 1979;37:367–75.PubMedCentralPubMed
24.
Zurück zum Zitat Ha CG, Cho JK, Lee CH, Chai YG, Ha YA, Shin SH. Cholesterol lowering effect of Lactobacillus plantarum isolated from human feces. J Microbiol Biotechnol. 2006;16:1201–9. Ha CG, Cho JK, Lee CH, Chai YG, Ha YA, Shin SH. Cholesterol lowering effect of Lactobacillus plantarum isolated from human feces. J Microbiol Biotechnol. 2006;16:1201–9.
25.
Zurück zum Zitat Lee HM, Lee YH. Isolation of Lactobacillus plantarum from kimchi and its inhibitory activity on the adherence and growth of Helicobacter pylori. J Microbiol Biotechnol. 2006;16:1513–7. Lee HM, Lee YH. Isolation of Lactobacillus plantarum from kimchi and its inhibitory activity on the adherence and growth of Helicobacter pylori. J Microbiol Biotechnol. 2006;16:1513–7.
26.
Zurück zum Zitat Lehner MD, Morath S, Michelsen KS, Schumann RR, Hartung T. Induction of cross-tolerance by lipopolysaccharide and highly purified lipoteichoic acid via different toll-like receptors independent of paracrine mediators. J Immunol. 2001;8:5161–7.CrossRef Lehner MD, Morath S, Michelsen KS, Schumann RR, Hartung T. Induction of cross-tolerance by lipopolysaccharide and highly purified lipoteichoic acid via different toll-like receptors independent of paracrine mediators. J Immunol. 2001;8:5161–7.CrossRef
27.
Zurück zum Zitat Guo Y, Xu F, Lu T, Duan Z, Zhang Z. Interleukin-6 signaling pathway in targeted therapy for cancer. Cancer Treat Rev. 2012;38:904–10.PubMedCrossRef Guo Y, Xu F, Lu T, Duan Z, Zhang Z. Interleukin-6 signaling pathway in targeted therapy for cancer. Cancer Treat Rev. 2012;38:904–10.PubMedCrossRef
28.
Zurück zum Zitat Knapp S, von Aulock S, Leendertse M, Haslinger I, Draing C, Golenbock DT, van der Poll T. Lipoteichoic acid-induced lung inflammation depends on TLR2 and the concerted action of TLR4 and the platelet-activating factor receptor. J Immunol. 2008;180:3478–84.PubMedCrossRef Knapp S, von Aulock S, Leendertse M, Haslinger I, Draing C, Golenbock DT, van der Poll T. Lipoteichoic acid-induced lung inflammation depends on TLR2 and the concerted action of TLR4 and the platelet-activating factor receptor. J Immunol. 2008;180:3478–84.PubMedCrossRef
29.
Zurück zum Zitat Song J, Duncan MJ, Li G, Chan C, Grady R, Stapleton A, Abraham SN. A novel TLR4-mediated signaling pathway leading to IL-6 responses in human bladder epithelial cells. PLoS Pathog. 2007;3:e60.PubMedCentralPubMedCrossRef Song J, Duncan MJ, Li G, Chan C, Grady R, Stapleton A, Abraham SN. A novel TLR4-mediated signaling pathway leading to IL-6 responses in human bladder epithelial cells. PLoS Pathog. 2007;3:e60.PubMedCentralPubMedCrossRef
30.
Zurück zum Zitat Hirohashi N, Morrison DC. Low-dose lipopolysaccharide (LPS) pretreatment of mouse macrophages modulates LPS-dependent interleukin-6 production in vitro. Infect Immun. 1996;64:1011–5.PubMedCentralPubMed Hirohashi N, Morrison DC. Low-dose lipopolysaccharide (LPS) pretreatment of mouse macrophages modulates LPS-dependent interleukin-6 production in vitro. Infect Immun. 1996;64:1011–5.PubMedCentralPubMed
31.
Zurück zum Zitat Maitra U, Deng H, Glaros T, Baker B, Capelluto DG, Li Z, Li L. Molecular mechanisms responsible for the selective and low-grade induction of proinflammatory mediators in murine macrophages by lipopolysaccharide. J Immunol. 2012;189:1014–23.PubMedCentralPubMedCrossRef Maitra U, Deng H, Glaros T, Baker B, Capelluto DG, Li Z, Li L. Molecular mechanisms responsible for the selective and low-grade induction of proinflammatory mediators in murine macrophages by lipopolysaccharide. J Immunol. 2012;189:1014–23.PubMedCentralPubMedCrossRef
32.
Zurück zum Zitat Islam MA, Pröll M, Hölker M, Tholen E, Tesfaye D, Looft C, Schellander K, Cinar MU. Alveolar macrophage phagocytic activity is enhanced with LPS priming, and combined stimulation of LPS and lipoteichoic acid synergistically induce pro-inflammatory cytokines in pigs. Innate Immun. 2013;19:631–43.PubMedCrossRef Islam MA, Pröll M, Hölker M, Tholen E, Tesfaye D, Looft C, Schellander K, Cinar MU. Alveolar macrophage phagocytic activity is enhanced with LPS priming, and combined stimulation of LPS and lipoteichoic acid synergistically induce pro-inflammatory cytokines in pigs. Innate Immun. 2013;19:631–43.PubMedCrossRef
Metadaten
Titel
Differential effects of low and high doses of lipoteichoic acid on lipopolysaccharide-induced interleukin-6 production
verfasst von
Hangeun Kim
Bong Jun Jung
Joo Yun Kim
Dae Kyun Chung
Publikationsdatum
01.06.2014
Verlag
Springer Basel
Erschienen in
Inflammation Research / Ausgabe 6/2014
Print ISSN: 1023-3830
Elektronische ISSN: 1420-908X
DOI
https://doi.org/10.1007/s00011-014-0714-8

Weitere Artikel der Ausgabe 6/2014

Inflammation Research 6/2014 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.